Miranza

What Miranza does

Miranza Inversiones Oftalmológicas, S.L. is a privately held ophthalmology group headquartered in Madrid, Spain, operating a network of approximately 30 clinic brands across Spain, Portugal, and Andorra. The group functions as a roll-up platform under the Veonet multinational healthcare conglomerate, retaining acquired brand identities (IMO, Vissum, IOA, Begitek, IBO, Oculsur, Tecnolaser, and others) while centralizing quality management, R&D, and corporate governance. Services span comprehensive eye care including clinical diagnostics, high-complexity outpatient surgery (cataract, refractive, cornea, glaucoma, retina), oculoplastics, pediatric ophthalmology, dry eye treatment, and aesthetic eye procedures, with teleconsultation capabilities for remote patients and international clientele.

The group operates a direct-to-consumer business model, generating revenue through patient consultations, diagnostic testing, surgical procedures, and aesthetic eye services across physical clinics, with online appointment booking, callback services, and WhatsApp contact as primary access points. Miranza's pricing is quote-based and not publicly disclosed. The group maintains a substantial R&D&I infrastructure with over 300 researchers, 100+ active projects, 200+ scientific publications, and 6,400+ patients recruited for clinical studies, collaborating with major pharmaceutical firms (Alcon, Novartis, AbbVie, Roche, Bayer, Regeneron, J&J) and Spanish universities. The organization holds ISO 9001, ISO 7101, UNE 179003, and ISO 14001 certifications across its network.

Miranza's go-to-market emphasizes premium surgery without waiting times, advanced technology positioning, and multi-language accessibility (Spanish, English, Portuguese). Distribution combines physical clinic visits, digital appointment channels, teleconsultation, and a content ecosystem including the 'Miradas que hablan' podcast and active social media presence. Recent strategic activity has focused on inorganic growth through clinic acquisitions and partnership-driven R&D expansion rather than technology platform development.

Name

Miranza

Legal name

Miranza Inversiones Oftalmológicas, S.L.

Website

https://miranza.es/

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Miranza is a private Spanish ophthalmology group operating 30 clinic brands across Spain, Portugal, and Andorra under parent Veonet, offering diagnostic, surgical, and aesthetic eye care services with a large R&D program and pharmaceutical partnerships.

Ownership category

akta.pro rank

Product category

Ophthalmology Clinics

NAICS

Offices of Optometrists (62132), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

akta.pro secondary industries

Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery) (HLAKAKAO), Ophthalmology Surgery Centers (HLAFAIAF), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)

Keywords

• Ophthalmology services
• Eye care clinics
• Cataract surgery
• Refractive surgery
• Pediatric ophthalmology

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices21 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain, Others

Revenue model

1. Clinical Consultation Services: Revenue generated from patient consultations across all 30 clinic locations covering general ophthalmology and specialty areas including retina, cornea, glaucoma, pediatrics, oculoplastics, and aesthetic eye services.
2. Surgical Procedures: High-complexity outpatient eye surgery services including cataract surgery, refractive surgery (lens replacement), cornea transplants, and other surgical interventions. Premium surgery without waiting times is emphasized.
3. Diagnostic Testing: Clinical diagnostic services including eye examinations, imaging tests, and specialized diagnostics for various ocular pathologies.
4. Aesthetic Services: Aesthetic procedures related to eye area ('Estética de la mirada') including treatments for bags under eyes, eyelid procedures performed by specialists.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Miranza operates a network of approximately 30 ophthalmology clinics across Spain, Portugal, and Andorra, providing comprehensive eye care that spans clinical diagnostics, high-complexity outpatient eye surgery (cataract, refractive, cornea, glaucoma, retina, oculoplastics, and pediatric ophthalmology), aesthetic eye procedures, teleconsultation, and second opinions. Its offering is unified by ISO-certified quality, patient safety, and environmental management systems, and is supported by a coordinated R&D&I program with active clinical trials.

Product overview

Miranza is a leading ophthalmology group in Spain comprising approximately 30 clinic brands across the Iberian Peninsula and Andorra. The portfolio includes flagship specialized eye surgery centers (IMO Grupo Miranza, Vissum Grupo Miranza, IOA), regional clinic brands (Begitek, Clínica Begoña, Clínica Muiños, Clínica Palomares, IBO, Oculsur, Ókular, Ophthalteam, and others), and Portuguese clinics (Miranza Oftalmocenter, Miranza Coantas). The group offers a comprehensive range of eye care services unified under a shared quality management system: diagnostic clinical services, medical and surgical treatments (cataract, refractive, cornea, glaucoma, retina), aesthetic services, and teleconsultation for remote patient evaluation. Research and innovation activities span multiple ophthalmology subspecialties through the R&D&I program.

Differentiator

Problem solved

Functional benefit

Brands

• Miradas que hablan: Podcast series featuring dialogues between doctors of different centers, generations, and specialties discussing topics related to vision and ophthalmology

Products and services

• Ophthalmology Clinic Network (Miranza clinics) A network of approximately 30 specialized ophthalmology clinics across Spain, Portugal, and Andorra operating under brands such as IMO Grupo Miranza, Vissum Grupo Miranza, Miranza IOA, Miranza Begitek, Miranza Clínica Muiños, Miranza IBO, Miranza Oculsur, Miranza Ophthalteam, Miranza Tecnolaser, Miranza Oftalmocenter, Miranza Coantas, and Miranza Clínica El Brillante; provides physical access points for ophthalmology consultations, diagnostics, surgery, and follow-up care.
• Clinical Diagnostic Services Comprehensive eye diagnostic services including clinical examinations and specialized testing for various ocular pathologies, delivered at Miranza's network of clinics for adult and pediatric patients.
• Eye Surgery and Treatment Services Medical and surgical ophthalmology treatments including cataract surgery, refractive surgery (intraocular lenses for myopia/hyperopia/presbyopia), cornea treatments and transplants, glaucoma management, retina treatments, oculoplastic procedures, pediatric ophthalmology, and strabismus surgery; positioned as premium surgery without waiting times.
• Aesthetic Eye Services Aesthetic procedures related to the eye area ('Estética de la mirada') including eyelid aesthetics and facial rejuvenation around the eyes, performed by specialist ophthalmologists.
• Teleconsultation and Second Opinion Service Remote ophthalmology consultation service delivered via video conference or telephone, allowing patients to obtain expert evaluation, second opinions, medical guidance, prescriptions, and written reports from home; available at IMO Grupo Miranza (Barcelona, Madrid, Andorra, Manresa), Miranza IOA, and Vissum Grupo Miranza (Alicante, Lorca, Torrevieja); teleconsultation price is deducted from subsequent in-person visit within one month.

Quantifiable outcome

• Blindness is preventable 80% of the time through proper eye care
• +1 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature2 records

Partnerships

13 partnerships are on record, tiered core, flagship and minor.

• Dompé Farmaceutici S.p.A.coreTechnology or Integration · 1 March 2026International pharmaceutical partner collaborating on R&D&I projects in ophthalmology. Located in Italy.
• AlconcoreTechnology or Integration · 1 March 2026Major ophthalmology equipment and pharmaceutical company (Sweden) collaborating on research and innovation projects.
• Novartis / GyroscopecoreTechnology or Integration · 1 March 2026Collaboration with Novartis subsidiary Gyroscope (Sweden) on ophthalmology research and innovative therapies.
• AbbVie Inc.coreTechnology or Integration · 1 March 2026Global pharmaceutical company (USA) partnering on ophthalmology R&D&I projects.
• RochecoreTechnology or Integration · 1 March 2026International pharmaceutical collaboration (Sweden) on ophthalmology research.
• Bayer HealthcarecoreTechnology or Integration · 1 March 2026Pharmaceutical collaboration (Germany) on eye disease research.
• Regeneron Pharmaceuticals Inc.coreTechnology or Integration · 1 March 2026USA-based biotechnology company collaborating on innovative ophthalmology therapies.
• Johnson & JohnsoncoreTechnology or Integration · 1 March 2026Healthcare company (USA) collaboration on ophthalmology R&D.
• Universidades (Universidad Autónoma de Madrid, Universidad Complutense de Madrid, Universidad de Alicante, Universidad de Sevilla, Universidad Miguel Hernández, Universitat Politècnica de Catalunya, Universidad Internacional de Cataluña)coreStrategic or Co-development Partner · 1 March 2026Collaborations with multiple Spanish universities for R&D&I projects in ophthalmology, including clinical research, technological development, and academic partnerships.
• Hospital Universitario Puerta del Hierro MajadahondacoreStrategic or Co-development Partner · 1 March 2026Collaboration with major university hospital for clinical research projects.
• VeonetflagshipOthers · 31 July 2025Veonet is the parent company of Miranza. Miranza follows Veonet's Supplier Code of Conduct detailing commitment to international laws, UN conventions, International Labour Organisation guidelines, and Children's Rights and Business Conduct guidelines. Miranza also uses Veonet's ESG governance arrangements and complaints procedure including the whistleblowing hotline.
• ONEtoONE Corporate FinanceminorImplementation/ SI/ Consulting Partner · 31 July 2025Corporate finance advisory firm that advised Miranza on the acquisition of Tecnolaser Clinic Vision, a specialized eye surgery clinic in Seville.
• Non-profit organizations and public administrationscoreOthersMiranza works in partnership with non-profit organizations, public administrations, and companies to provide social action initiatives, offering free eye care prevention and treatment for vulnerable populations.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Grupo Innova Ocular: Spanish network of ophthalmology clinics with a multi-site private-pay model. Direct comparator to Miranza in scale, geography and clinical offering (cataract, refractive, retina, glaucoma).
• Optical Express: UK-based eye-care group operating clinics across Europe performing laser eye surgery, cataract, lens replacement and other ophthalmic procedures. Comparable in scale and clinical service breadth.
• Clínica Baviera: Spain's largest ophthalmology clinic chain with ~70+ clinics across Spain, Italy, Germany and Austria. Directly comparable specialist eye-care network with similar surgical service mix (cataract, refractive, glaucoma, retina) and retail/private-pay orientation.
• Vista Oftalmólogos: Network of ophthalmology clinics across Spain offering cataract, refractive, glaucoma and pediatric ophthalmology. Comparable multi-site private eye-care operator in the same Spanish market.
• Oftalvist: Spanish ophthalmology clinic group operating multiple centers across Spain with cataract, refractive, retina and oculoplastic services. Closest Iberian peer in scope and multi-site private-pay model.
• Optegra: Multi-country ophthalmology hospital and clinic operator (UK, Poland, Czechia, Germany). Comparable specialty eye-care platform with premium positioning and surgical focus.

Broad incumbents

• Quirónsalud: Spain's largest private hospital group, owned by Fresenius. Offers ophthalmology among broader multi-specialty services. Comparable via Spanish private-pay healthcare infrastructure but not specialty-focused.
• HM Hospitales: Large Spanish private hospital group with ophthalmology departments. Overlapping patient pool and Spanish private-pay dynamics, but operates as a multi-specialty incumbent rather than an eye-care specialist.

Emerging players

• Alain Afflelou: European optical retail chain expanding into refractive and clinical eye-care services. Adjacent rather than overlapping; an emerging competitor blending retail optics with clinical ophthalmology.

Others

• Veonet (parent group peers): Veonet is the multinational ophthalmology platform that owns Miranza. Other Veonet-affiliated eye-care groups in other geographies share Miranza's clinical, governance and ESG standards and are useful comparators for group-level economics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/GrupoMiranza
• YouTubeyoutube.com/channel/UCX2gEI-gOFCbPHZ7QSTkLYQ/featured
• Facebookfacebook.com/GrupoMiranza
• LinkedInlinkedin.com/company/grupomiranza
• Instagraminstagram.com/grupomiranza

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries20 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Miranza